Amedisys, Inc. (NASDAQ:AMED) Shares Bought by Trexquant Investment LP

Trexquant Investment LP boosted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 1,317.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 87,719 shares of the health services provider's stock after purchasing an additional 81,532 shares during the period. Trexquant Investment LP owned about 0.27% of Amedisys worth $7,964,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AMED. Blue Trust Inc. grew its stake in shares of Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after buying an additional 124 shares in the last quarter. HBW Advisory Services LLC purchased a new stake in shares of Amedisys during the fourth quarter worth approximately $38,000. Versant Capital Management Inc raised its holdings in Amedisys by 68.5% in the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock valued at $41,000 after acquiring an additional 183 shares in the last quarter. Vestcor Inc purchased a new position in Amedisys in the fourth quarter worth approximately $73,000. Finally, Venturi Wealth Management LLC grew its holdings in Amedisys by 397.4% during the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after acquiring an additional 779 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Stephens restated an "equal weight" rating and issued a $101.00 price objective on shares of Amedisys in a report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, Amedisys presently has a consensus rating of "Hold" and a consensus price target of $101.00.

Remove Ads

Amedisys Stock Up 0.8 %

Amedisys stock traded up $0.72 during mid-day trading on Wednesday, hitting $92.03. The company had a trading volume of 459,691 shares, compared to its average volume of 399,890. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95. The business has a fifty day moving average of $92.23 and a 200 day moving average of $92.13. The stock has a market cap of $3.02 billion, a price-to-earnings ratio of 36.52, a PEG ratio of 1.78 and a beta of 0.89.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company had revenue of $598.05 million for the quarter, compared to analyst estimates of $602.38 million. On average, sell-side analysts expect that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.